305 related articles for article (PubMed ID: 18628999)
1. The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy.
Kuiper EJ; Van Nieuwenhoven FA; de Smet MD; van Meurs JC; Tanck MW; Oliver N; Klaassen I; Van Noorden CJ; Goldschmeding R; Schlingemann RO
PLoS One; 2008 Jul; 3(7):e2675. PubMed ID: 18628999
[TBL] [Abstract][Full Text] [Related]
2. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.
Van Geest RJ; Lesnik-Oberstein SY; Tan HS; Mura M; Goldschmeding R; Van Noorden CJ; Klaassen I; Schlingemann RO
Br J Ophthalmol; 2012 Apr; 96(4):587-90. PubMed ID: 22289291
[TBL] [Abstract][Full Text] [Related]
3. Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy.
Van Geest RJ; Klaassen I; Lesnik-Oberstein SY; Tan HS; Mura M; Goldschmeding R; Van Noorden CJ; Schlingemann RO
J Cell Commun Signal; 2013 Mar; 7(1):1-9. PubMed ID: 23054594
[TBL] [Abstract][Full Text] [Related]
4. The role of CTGF in diabetic retinopathy.
Klaassen I; van Geest RJ; Kuiper EJ; van Noorden CJ; Schlingemann RO
Exp Eye Res; 2015 Apr; 133():37-48. PubMed ID: 25819453
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy.
Hinton DR; Spee C; He S; Weitz S; Usinger W; LaBree L; Oliver N; Lim JI
Diabetes Care; 2004 Mar; 27(3):758-64. PubMed ID: 14988298
[TBL] [Abstract][Full Text] [Related]
6. Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye.
Kuiper EJ; de Smet MD; van Meurs JC; Tan HS; Tanck MW; Oliver N; van Nieuwenhoven FA; Goldschmeding R; Schlingemann RO
Arch Ophthalmol; 2006 Oct; 124(10):1457-62. PubMed ID: 17030714
[TBL] [Abstract][Full Text] [Related]
7. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
8. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
9. Expression of stromal cell-derived factor-1 in diabetic retinopathy.
Chen LY; Zhuo YH; Li YH; Huang XH; Zhang JL; Li SY; Wang XG; Lü L
Chin Med J (Engl); 2010 Apr; 123(8):984-8. PubMed ID: 20497701
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Lecube A; Segura RM; Sararols L; Simó R
Diabet Med; 2002 Aug; 19(8):655-60. PubMed ID: 12147146
[TBL] [Abstract][Full Text] [Related]
11. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
[TBL] [Abstract][Full Text] [Related]
12. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
Zheng B; Li T; Chen H; Xu X; Zheng Z
Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
[TBL] [Abstract][Full Text] [Related]
13. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
[TBL] [Abstract][Full Text] [Related]
14. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
15. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Deng J; Wu DZ; Gao R
Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice.
Kuiper EJ; Roestenberg P; Ehlken C; Lambert V; van Treslong-de Groot HB; Lyons KM; Agostini HJ; Rakic JM; Klaassen I; Van Noorden CJ; Goldschmeding R; Schlingemann RO
J Histochem Cytochem; 2007 Nov; 55(11):1139-47. PubMed ID: 17625227
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.
Babapoor-Farrokhran S; Jee K; Puchner B; Hassan SJ; Xin X; Rodrigues M; Kashiwabuchi F; Ma T; Hu K; Deshpande M; Daoud Y; Solomon S; Wenick A; Lutty GA; Semenza GL; Montaner S; Sodhi A
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3030-9. PubMed ID: 26039997
[TBL] [Abstract][Full Text] [Related]
18. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
Umeda N; Ozaki H; Hayashi H; Kondo H; Uchida H; Oshima K
Ophthalmic Res; 2002; 34(1):43-7. PubMed ID: 11834884
[TBL] [Abstract][Full Text] [Related]
19. Expression of angiopoietin-like protein 8 correlates with VEGF in patients with proliferative diabetic retinopathy.
Lu Q; Lu L; Chen W; Lu P
Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1515-1523. PubMed ID: 28456825
[TBL] [Abstract][Full Text] [Related]
20. Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders.
Abu El-Asrar AM; Van den Steen PE; Al-Amro SA; Missotten L; Opdenakker G; Geboes K
Int Ophthalmol; 2007 Feb; 27(1):11-22. PubMed ID: 17375263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
